Dermatology · Fairport, NY
NPI
1871798868
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
6800 Pittsford Palmyra Rd Ste 150
Fairport, NY, 14450
Phone (585) 364-1177
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
238 services
Medicare patients, 2024
49
Average age 77
Drug cost, 2024
$1.9M
456 prescriptions
Company payments, 2025
$452
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian Poligone was code 99215 (office e&m - established), 98 times for 42 patients. In total Brian Poligone billed 238 services in 14 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 98 | 42 | $130.28 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 74 | 38 | $12.33 | $912 |
By year: 2022 $18K for 215 services; 2023 $17K for 188 services; 2024 $17K for 238 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian Poligone prescribed most often to Medicare patients was Betamethasone Dipropionate, with 60 prescriptions and refills. In total Brian Poligone wrote 456 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Dipropionate Generic | 60 | 60 | 13 | $1,497 |
| Valchlor Mechlorethamine Hcl | 52 | 52 | 14 | $395K |
| Bexarotene Generic | 47 | 47 | Under 11 | $1.3M |
| Methotrexate Methotrexate Sodium | 35 | 47 | Under 11 | $802 |
| Levothyroxine Sodium Generic | 29 | 49 | Under 11 | $2,013 |
| Clobetasol Propionate Generic | 29 | 37 | Under 11 | $1,110 |
| Imiquimod Generic | 27 | 33 | Under 11 | $771 |
| Triamcinolone Acetonide Generic | 19 | 32 | 14 | $207 |
| Dupixent Syringe Dupilumab | 15 | 15 | Under 11 | $56K |
| Atorvastatin Calcium Generic | 15 | 31 | Under 11 | $85.23 |
| Pegasys Peginterferon Alfa-2a | 12 | 12 | Under 11 | $98K |
Brand drugs: 112 claims; generic drugs: 344 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian Poligone $452 ($452 in general payments such as food, travel and fees) from 14 companies. The largest payer was Lilly USA, LLC with $122.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 3 | $122 |
| Incyte Corporation INCY | 2 | $111 |
| Abbvie Inc. ABBV | 3 | $66.99 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $24.39 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $23.15 |
| Therakos LLC | 1 | $21.75 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $20.67 |
| Paratek Pharmaceuticals, Inc. | 1 | $18.33 |
| SpringWorks Therapeutics, Inc. | 1 | $14.94 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $14.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.